NEW ACNP JOURNAL: NPP-Digital Psychiatry and Neuroscience
The ACNP is delighted to announce the launch of an Open-Access, online-only journal entitled NPP-Digital Psychiatry and Neuroscience. This new journal will function in parallel with the flagship ACNP journal, Neuropsychopharmacology (NPP). Check us out at www.nature.com/dpn!
The scope of NPP-Digital Psychiatry and Neuroscience will cover research that involves the use of digital technologies, including (but not restricted to) smart devices, wireless telemetry, motion sequencing, artificial intelligence, machine learning, bioinformatics, and computational approaches in the diagnosis, treatment, prevention, and study of psychiatric illnesses. This journal will prioritize publishing research that is translationally relevant (endpoints that can be used across species), and involves data sets that are continuous (collected over time) and objective (requiring minimal direct human observation). Led by Principal Editor William A. Carlezon Jr., NPP-Digital Psychiatry and Neuroscience will have an editorial team with expertise in these domains.
NEW IN 2024: DPN Editors’ New Investigator Waiver Award
DPN is offering an opportunity to waive the article processing charge ($2090) for new investigators who recently established their independent research program and wish to publish their research report in DPN. Investigators who launched their program in a field supported by DPN within the last 5 years are eligible to apply. Deadline is May 1, 2025.
Journal Leadership & Management:
Founding Organization: The American College of Neuropsychopharmacology (ACNP)
Principal Editor: William A. Carlezon Jr., Ph.D.
Sibling Journal: Neuropsychopharmacology (NPP)
Journal Aims & Scope:
NPP-Digital Psychiatry and Neuroscience aims to be the leading publication for research that employs the use of digital-based methodologies for the collection and analysis of psychiatry data. This Open-Access, online-only journal will serve as a trusted resource for those researchers involved in the study, diagnosis, treatment, or prevention of psychiatric illness. As such, the journal focuses on brain conditions which are characterized as psychiatric disorders, while excluding other brain conditions that may otherwise be more broadly characterized as neurological disorders (as examples: Amyotrophic Lateral Sclerosis, Epilepsy, Multiple Sclerosis, Parkinson’s Disease).
To qualify for consideration in this journal, research should involve digital data collection (e.g., via smart phones, wearables, implantables, videotaping, motion sequencing, or other methods of tracking) and/or analyses (e.g., via machine learning, artificial intelligence, computational and/or bioinformatics) in humans or model systems, including laboratory animals of various species.
Submissions to NPP-Digital Psychiatry and Neuroscience should include data that meet the following criteria:
- Translational relevance (endpoints similar or identical across species),
- Continuous (involving sustained or repeated data collection), and
- Objective (collected, analyzed, and interpreted via methods involving minimal subjective judgements and/or anthropomorphic projection of human traits).
Successful articles will provide novel and impactful insights that advance the diagnosis of psychiatric illness or its core features, characterization of cellular mechanisms, assessment of therapeutic efficacy, identification of new therapeutic targets or methods, and/or prevention of new cases. The focus on translational alignment is intended to promote improvements in the ability of model systems to predict outcomes in humans and hasten the development of transformational treatments for psychiatric illness.
If you have additional questions, please contact the journal at dpnjournal@acnp.org.